U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H17N3.2ClH
Molecular Weight 324.248
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MIDAGLIZOLE DIHYDROCHLORIDE

SMILES

Cl.Cl.C(C(C1=CC=CC=C1)C2=NC=CC=C2)C3=NCCN3

InChI

InChIKey=PAKRIOPMNVCTCL-UHFFFAOYSA-N
InChI=1S/C16H17N3.2ClH/c1-2-6-13(7-3-1)14(12-16-18-10-11-19-16)15-8-4-5-9-17-15;;/h1-9,14H,10-12H2,(H,18,19);2*1H

HIDE SMILES / InChI

Description

Midaglizole (also known as DG 5128) is a α2 adrenoceptor antagonist. Daiichi Pharmaceutical developed this drug as an oral antidiabetic agent and to treat asthma. However, further study of this drug was discontinued.

Originator

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Effect of an alpha 2-adrenoceptor antagonist, midaglizole, on bronchial responsiveness to histamine in patients with mild asthma.
1995
Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
1991-01
Metabolic fate of the oral hypoglycaemic agent, midaglizole, in rats.
1989-06

Sample Use Guides

In Vivo Use Guide
Oral administration of DG-5128 (MIDAGLIZOLE) significantly (P less than .05) enhanced insulin secretion both 30 and 60 min after a mixed meal (550 kcal), with a concomitant decrease in postprandial plasma glucose levels at 60 and 120 min
Route of Administration: Oral
Name Type Language
MIDAGLIZOLE DIHYDROCHLORIDE
Common Name English
DG 5128
Preferred Name English
PYRIDINE, 2-(2-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-1-PHENYLETHYL)-, HYDROCHLORIDE (1:2)
Systematic Name English
MIDAGLIZOLE HYDROCHLORIDE [JAN]
Common Name English
Code System Code Type Description
PUBCHEM
157562
Created by admin on Mon Mar 31 23:12:56 GMT 2025 , Edited by admin on Mon Mar 31 23:12:56 GMT 2025
PRIMARY
FDA UNII
L29WU6X3A2
Created by admin on Mon Mar 31 23:12:56 GMT 2025 , Edited by admin on Mon Mar 31 23:12:56 GMT 2025
PRIMARY
EPA CompTox
DTXSID601000667
Created by admin on Mon Mar 31 23:12:56 GMT 2025 , Edited by admin on Mon Mar 31 23:12:56 GMT 2025
PRIMARY
CAS
79689-25-1
Created by admin on Mon Mar 31 23:12:56 GMT 2025 , Edited by admin on Mon Mar 31 23:12:56 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of MIDAGLIZOLE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966